JAZZ PHA reported 126.35M in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aerie Pharmaceuticals AERI:US $ -18137000 15.51M
ALKERMES ALKS:US -34457000 7.87M
Amarin AMRN:US -37619000 9.31M
Cara Therapeutics CARA:US $ -4472000 23.44M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Emergent Biosolutions EBS:US $ -72000000 78.4M
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Hikma Pharmaceutical HIK:LN 256M 23M
Horizon Pharma HZNP:US 147M 49.44M
Lannett LCI:US $ -20301000 2.47M
Mckesson MCK:US $ 1074M 340M
Merk MRK:US $ 5711M 652M
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Pacira Pharmaceuticals PCRX:US $ 13.18M 8.55M
Perrigo Ordinary Shares PRGO:US $ 2.6M 20.5M
Pfizer PFE:US $ 12099M 2104M
Phibro Animal Health PAHC:US $ 19.19M 3.1M
Revance Therapeutics RVNC:US $ -57842000 4.38M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Teva Pharmaceutical Industries TEVA:US 734M 55M
Xeris Pharmaceuticals Inc XERS:US $ -18916000 158K
Zoetis ZTS:US $ 737M 57M